Jaguar Health (JAGX) EBT Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
2.76 Mn |
| Date | Value |
| Mar 31, 2026 |
2.76 Mn |
| Dec 31, 2025 |
2.50 Mn |
| Sep 30, 2025 |
8,734.00 |
| Jun 30, 2025 |
-3,302.00 |
| Mar 31, 2025 |
9.03 Mn |
| Dec 31, 2024 |
37,898.00 |
| Sep 30, 2024 |
161,281.00 |
| Jun 30, 2024 |
336,146.00 |
| Mar 31, 2024 |
56,922.00 |
| Dec 31, 2023 |
-30,992.00 |
| Sep 30, 2023 |
402.00 |
| Jun 30, 2023 |
6.55 Mn |
| Mar 31, 2023 |
-420,771.00 |
| Dec 31, 2022 |
-2.53 Mn |
| Sep 30, 2022 |
37,515.00 |
| Jun 30, 2022 |
51,552.00 |
| Mar 31, 2022 |
-9.03 Mn |
| Dec 31, 2021 |
12,228.00 |
| Sep 30, 2021 |
-139,301.00 |
| Jun 30, 2021 |
-283,383.00 |